Jamshid Gholizadeh Navashenaq

The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019

Khanh Bao Tran, Justin J. Lang, Kelly Compton et al. · The Lancet · 2022 · 886 citations · Full text

The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019

Elysia Alvarez, Lisa M Force, Rixing Xu et al. · The Lancet Oncology · 2021 · 264 citations · Full text

RETRACTED: Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID‐19 patients

Safa Tahmasebi, Mohamed A. El‐Esawi, Zaid Hameed Mahmoud et al. · Journal of Cellular Physiology · 2020 · 115 citations

Clinical Immunology, Th17 Cell Responses, Immunodeficiencies +26

Molecular and cellular mechanisms of the effects of Propolis in inflammation, oxidative stress and glycemic control in chronic diseases

Naseh Pahlavani, Mahsa Malekahmadi, Safieh Firouzi et al. · Nutrition & Metabolism · 2020 · 95 citations · Full text

MPL nano-liposomal vaccine containing P5 HER2/neu-derived peptide pulsed PADRE as an effective vaccine in a mice TUBO model of breast cancer

Parvin Zamani, Jamshid Gholizadeh Navashenaq, Amin Reza Nikpoor et al. · Journal of Controlled Release · 2019 · 77 citations

Vaccination, Nanomedicine, Nanotherapeutics +11